Abstract
It is now well established that there is a proliferation of central dopamine D2 receptors in postmortem brains of schizophrenic patients (Seeman 1987; Toru et al. 1988). However, controversy persists as to whether these changes are due to chronic neuroleptic drug treatment, which itself enhances B max values of D2 receptors (Owen et al. 1980; Mackenzie and Zigmond 1985). To pursue this question we investigated the time course of D2 receptors after withdrawal of chronic neuroleptic treatment in human postmortem brain tissue (Kornhuber et al. 1989b). Furthermore, we studied the relationship between binding parameters of D2 receptors and both psychopathology and presence of tardive dyskinesia prior to death.
J. K. has received a scholarship grant from the Deutsche Forschungsgemeinschaft.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alfredsson G, Wiesel FA, Tylec A (1988) Relationship between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers. Biol Psychiatry 23: 689–697
Allen RM, Young SJ (1978) Phencyclidine-induced psychosis. Am J Psychiatry 135: 1081–1084
Anis NA, Berry SC, Burton NR, Lodge D (1983) The dissociative anaesthetics, ketamine and phencyclidine selectively reduce excitation of central mammalian neurons by JV-methyl- aspartate. Br J Pharmacol 79: 565–575
Deakin JFW, Simpson MDC, Gilchrist AC, Skan WJ, Slater P (1988) Cortical glutamate dysfunction in schizophrenia. Psychopharmacology 96S: 108
Etienne P, Baudry M (1987) Calcium dependent aspects of synaptic plasticity, excitatory amino acid neurotransmission, brain aging and schizophrenia: a unifying hypothesis. Neurobiol Aging 8: 362–366
Fagg GE, Foster AC (1983) Amino acid neurotransmitters and their pathways in the mammalian central nervous system. Neuroscience 9: 701–719
Farde L, Wiesel FA, Hall H, Halldin C, Stone-Elander S, Sedvall G (1987) No D2 receptor increase in PET study of schizophrenia. Arch Gen Psychiatry 44: 671–672
Feighner JP, Robins E, Guze SB, Woodruff RA, Winokur G, Munoz R (1972) Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 26: 57–63
Foster AC, Fagg GE (1987) Taking apart NMDA receptors. Nature 329: 395–396
Gattaz WF, Gattaz D, Beckmann H (1982) Glutamate in schizophrenics and healthy controls. Arch Psychiatr Nervenkr 231: 221–225
Illowski BP, Juliano DM, Bigelow LB, Weinberger DR (1988) Stability of CT scan findings in schizophrenia: results of an 8 year follow-up study. J Neurol Neurosurg Psychiatry 51: 209–213
Iversen LL (1984) Amino acids and peptides: fast and slow chemical signals in the nervous system? Proc R Soc Lond [Biol] 221: 245–260
Jakob H, Beckmann H (1986) Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Trans 65: 154–161
Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmüller B (1980) Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 20: 379–382
Kim JS, Kornhuber HH, Kornhuber J, Kornhuber ME (1986) Glutamic acid and the dopamine hypothesis of schizophrenia. In: Chagass C, Josiassen RC, Bridger WH, Weiss HJ, Stoff D, Simpson GS (eds) Biological psychiatry 1985. Elsevier, Amsterdam, pp 1109–1111
Koek W, Woods JH, Ornstein P (1987) A simple and rapid method for assessing similarities among directly observable behavioral effects of drugs: PCP-like effects of 2-amino-5-phosphonovalerate in rats. Psychopharmacology 91: 297–304
Kornhuber HH, Kornhuber J, Kim JS, Kornhuber ME (1984) Zur biochemischen Theorie der Schizophrenie. Nervenarzt 55: 602–606
Kornhuber J, Fischer EG (1982) Glutamic acid diethyl ester induces catalepsy in rats. A new model for schizophrenia? Neurosci Lett 34: 325–329
Kornhuber J, Kornhuber ME (1986) Presynaptic dopaminergic modulation of cortical input to the striatum. Life Sci 39: 669–674
Kornhuber J, Mack-Burkhardt F, Riederer P, Hebenstreit GF, Reynolds GP, Andrews HB, Beckmann H (1989a) [3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients. J Neural Transm 77: 231–236
Kornhuber J, Riederer P, Reynolds GP, Beckmann H, Jellinger K, Gabriel E (1989b) 3H-Spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms. J Neural Transm 75: 1–10
Kornhuber ME, Kornhuber J, Zettlmeißl H, Kornhuber HH (1986) Phencyclidin und das glutamaterge System. In: Keup W (ed) Biologische Psychiatrie, Forschungsergebnisse. Springer, Berlin Heidelberg New York, pp 176–180
Korpi ER, Kleinman JE, Goodman SI, Wyatt J (1987) Neurotransmitter amino acids in post-mortem brains of chronic schizophrenic patients. Psychiatry Res 22: 291–301
Kötz A, Merkel P (1926) Zur Kenntnis hydroaromatischer Alkamine. J Prakt Chem 113: 49–79
Lodge D, Berry SC (1984) Psychotomimetic effects of sigma opiates may be mediated by block of central excitatory synapses utilizing receptors for aspartate-like amino acids. In: Bandler R (ed) Modulation of sensorimotor activity during alterations in behavioural states. Liss, New York, pp 503–518
Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R (1959) Study of a new schizo-phrenomimetic drug — Sernyl. Arch Neurol Psychiatry 81: 363–369
Mackay AVP, Iversen LL, Rossor M, Spokes E, Bird E, Arregui A, Creese I, Snyder SH (1982) Increased brain dopamine and dopamine receptors in schizophrenia. Arch Gen Psychiatry 39: 991–997
Mackenzie RG, Zigmond MJ (1985) Chronic neuroleptic treatment increases D-2 but not D-1 receptors in rat striatum. Eur J Pharmacol 113: 159–165
Nishikawa T, Takashima M, Toru N (1983) Increased 3H-kainic acid binding in the prefrontal cortex in schizophrenia. Neurosci Lett 40: 245–250
Owen F, Cross AJ, Waddington JL, Poulter M, Gamble SJ, Crow TJ (1980) Dopamine-mediated behaviour and 3H-spiperone binding to striatal membranes in rats after nine months haloperidol administration. Life Sci 26: 55–59
Perry TL (1982) Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction. Neurosci Lett 28: 81–85
Petersen RC, Stillman RC (1978) Phencyclidine: an overview, In: Petersen RC, Stillman RC (eds) NIDA Research Monograph, vol 21, pp 1–17
Schmidt WJ (1986) Intrastriatal injection of DL-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine. Psychopharmacology 90: 123–130
Schmidt WJ, Bubser M (1988) Anti-cataleptic effects of the N-methyl-aspartate antagonist MK-801. Pharmacol Biochem Behav 32: 621–623
Seeman P (1987) Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1: 133–152
Seeman P, Ulpian C, Bergeron C, Riederer P, Jellinger K, Gabriel E, Reynolds GP, Tourtellotte WW (1984) Bimodal distribution of dopamine receptor densities in brains of schizophrenics. Science 225: 728–731
Segal M, Landis S (1974) Afferents to the hippocampus of the rat studied with the method of retrograde transport of horseradish peroxidase. Brain Res 78: 1–15
Shelton RC, Karson CN, Doran AR, Pickar D, Bigelow LB, Weinberger DR (1988) Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defect. Am J Psychiatry 145: 154–163
Snyder SH (1980) Phencyclidine. Nature 285: 355–356
Storm-Mathisen J, Ottersen OP (1988) Localization of excitatory amino acid transmitter. In: Lodge D (ed) Excitatory amino acids in health and disease. Wiley, Chichester, pp 107–141
Toru M, Watanabe S, Shibuya H, Nishikawa T, Noda K, Mitsushio H, Ichikawa H, KurumajiA, Takashima M, Mataga N, Ogawa A (1988) Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients. Acta Psychiatr Scand 78: 121–137
Wong DF, Wagner HN, Tune LE, Dannals RF, Pearlson GD, Links JM, Tamminga CA, Broussolle EP, Ravert HT, Wilson AA, Toung JKT, Malat J, Williams JA, O’Tuama LA, Snyder SH, Kuhar MJ, Gjedde A (1986) Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science 234: 1558–1563
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kornhuber, J., Riederer, P., Beckmann, H. (1990). The Dopaminergic and Glutamatergic Systems in Schizophrenia. In: Bunney, W.E., Hippius, H., Laakmann, G., Schmauss, M. (eds) Neuropsychopharmacology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74034-3_70
Download citation
DOI: https://doi.org/10.1007/978-3-642-74034-3_70
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74036-7
Online ISBN: 978-3-642-74034-3
eBook Packages: Springer Book Archive